BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7037959)

  • 1. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes.
    Klempner MS; Rocklin RE
    J Immunol; 1982 May; 128(5):2040-3. PubMed ID: 7037959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcium in the activation of neutrophils by leukocyte inhibitory factor (LIF).
    Borish L; Rosenbaum R; Rocklin R
    Lymphokine Res; 1987; 6(4):341-9. PubMed ID: 3323675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte migration inhibition factor (LIF) increases polymorphonuclear cell endocytosis.
    Cortés-Castillo MA; Favila-Castillo L
    Arch Invest Med (Mex); 1991; 22(1):35-40. PubMed ID: 1819974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of leukocyte inhibitory factor (LIF) on neutrophil phagocytosis and bactericidal activity.
    Borish L; Rocklin RE
    J Immunol; 1987 Mar; 138(5):1475-9. PubMed ID: 2949016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF).
    Bendtzen K; Rocklin RE
    J Immunol; 1980 Oct; 125(4):1775-81. PubMed ID: 6251137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF).
    McCoy JL; Braatz JA; Ames RS; Herberman RB
    J Immunol; 1980 Jun; 124(6):2786-93. PubMed ID: 6989906
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial characterization of the vitamin D binding protein (Gc-globulin) binding site on the neutrophil plasma membrane: evidence for a chondroitin sulfate proteoglycan.
    DiMartino SJ; Kew RR
    J Immunol; 1999 Aug; 163(4):2135-42. PubMed ID: 10438954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of monosaccharides in the interaction of two lymphocyte mediators with their target cells.
    Rocklin RE
    J Immunol; 1976 Mar; 116(3):816-20. PubMed ID: 768376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of leukocyte inhibitory factor (LIF) on human neutrophil function.
    Klempner MS; Rocklin RE
    Inflammation; 1983 Jun; 7(2):145-53. PubMed ID: 6305834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties.
    Rocklin R
    Fed Proc; 1978 Nov; 37(13):2743-7. PubMed ID: 710595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes.
    Siegbahn A; Garcia RC; Kishi K; Nilsson K; Venge P
    Eur J Haematol; 1987 Aug; 39(2):172-9. PubMed ID: 3666104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
    Puppo F; Corsini G; Mangini P; Armani U; Piana A
    Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An indirect assay for canine leukocyte migration inhibitory factor (LIF): demonstration of its species specificity.
    Ansfield MJ; Shalaby MR; Kaltreider HB
    J Immunol Methods; 1980; 34(1):43-8. PubMed ID: 6448271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of neutrophil aggregation by human leukocyte inhibitory factor.
    Schainberg H; Borish L; Rocklin RE
    Inflammation; 1988 Jun; 12(3):203-11. PubMed ID: 2843462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine spermadhesin PSP-I/PSP-II stimulates macrophages to release a neutrophil chemotactic substance: modulation by mast cells.
    Assreuy AM; Alencar NM; Cavada BS; Rocha-Filho DR; Feitosa RF; Cunha FQ; Calvete JJ; Ribeiro RA
    Biol Reprod; 2003 May; 68(5):1836-41. PubMed ID: 12606406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic neuronal differentiation factor (CDF)/leukemia inhibitory factor (LIF) binds to specific regions of the developing nervous system in vivo.
    Qiu L; Bernd P; Fukada K
    Dev Biol; 1994 Jun; 163(2):516-20. PubMed ID: 8200484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.